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Abstract Drug-resistant varieties of pathogens are now a recognized global threat. Insights into the routes for drug
resistance in these pathogens are critical for developing more e®ective antibacterial drugs. A systems-level analysis of the
genes, proteins, and interactions involved is an important step to gaining such insights. This paper discusses some of the
computational challenges that must be surmounted to enable such an analysis; viz., unreliability of bacterial interactome
maps, paucity of bacterial interactome maps, and identi¯cation of pathways to bacterial drug resistance.
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1 Introduction
It is critical to address the emergence of drug-
resistant varieties of pathogens for infectious diseases,
especially those that have spread globally, such as drug-
resistant tuberculosis[1]. Approaches to counter drug
resistance have so far achieved limited success[2]. This
lack of success may be due to a lack of understanding
of how resistance emerges in bacteria upon drug treat-
ment. It has been proposed that a systems-level anal-
ysis of the genes, proteins, and interactions involved is
the key to gaining insights into routes required for drug
resistance[3].
One of pre-requisites of such an analysis is the exi-
stence of a comprehensive protein interactome of the
relevant pathogen. For example, let us assume that
a comprehensive protein interactome of Mycobacterium
tuberculosis is available. Then one can identify a mini-
mal set of proteins (or protein interactions) whose inhi-
bition would disconnect all essential pathways in M. tu-
berculosis. Alternatively, one can trace the interaction
route of the known targets of a drug to various e²ux
pump proteins and drug-modifying enzyme proteins[4].
Two yeast interactome maps[5-6] based on yeast
two-hybrid technology were published eight years ago.
Today, the quantity and variety of protein inter-
action data have increased rapidly. In particular,
two-hybrid-based interactome maps have been gene-
rated for model organisms such as C. elegans[7],
D. melanogaster[8], and human[9-10]. Proteome-scale
interactome maps have also been generated for yeast
by TAP-MS experiments[11-13]. However, very few
bacterial species[14-16] have been analyzed at the pro-
teome level for protein interactions. Furthermore, the
quality of these interactome maps has much to be
improved[17-18]. For example, out of nearly 10000 in-
teractions surveyed in [19], less than 25% were detected
in two di®erent assays. This implies high false positive
and false negative rates in the underlying biological as-
says.
Hence a systems-level analysis of proteins and their
interactions in pathogens of infectious diseases for iden-
tifying drug resistance pathways is di±cult. This is a
worthy problem for computational biologists. So, we
propose the following challenges in the systems-level
analysis of proteins and interactions in pathogens of
infectious diseases for identifying drug resistance path-
ways:
² Unreliability of bacterial interactome maps;
² Paucity of bacterial interactome maps;
² Identi¯cation of candidate pathways to drug resis-
tance in a bacterium.
Furthermore, we suggest using M. tuberculosis as a test
case. These challenges and some approaches are dis-
cussed in the remainder of this paper.
2 Unreliability of Bacterial Interactome Maps
Comprehensive and high-quality bacterial protein
interactome maps are needed to support reliable infe-
rence of pathways to drug resistance in bacteria.
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Unfortunately, the quality of available bacterial protein
interactome maps is likely to be low, as several stu-
dies show that existing interactome maps have a lot of
noise[17]. For example, while real protein interactions
are expected to be generally reproducible, it has been
found that no more than 25% of protein interactions
reported in various high-throughput experiments can
be detected in two or more di®erent high-throughput
assays[18-19]. As another example, while real protein
interactions are expected to be generally between pro-
teins in the same cellular compartments, no more than
55% of protein interactions in the DIP yeast protein in-
teraction database[20] are between proteins in the same
cellular compartments. Thus it is critical to develop
techniques to assess the reliability of protein interac-
tions in bacterial protein interactome maps. Also, these
interactome maps are still essentially an in vitro scaf-
fold and thus do not directly re°ect, e.g., in vivo protein
complexes[21]. It is critical to investigate techniques for
improving the reliability of interactome maps, as well
as techniques for inferring protein complexes from in-
teractome maps.
Protein reliability assessment has been made based
on the sharing of a common cellular localization or a
common functional role[19;22]. It has also been made
based on the reproducibility and non-randomness of
the observation of an interaction[23]. Related to the
ideas of functional homogeneity, localization coherence
and observational reproducibility are a large number
of other approaches[24] for estimating the reliability of
protein interactions based on the use of additional in-
formation, such as protein annotation, or the use of
information from multiple assays. Current state-of-the-
art approaches generally integrate multiple information
types into the reliability assessment process[25].
However, the additional information required by
these approaches may be unavailable, as is likely to
be the case in M. tuberculosis. Therefore, reliability
indices that do not require such information are criti-
cal. Recent work on reliability indices based purely on
the topology of the interactome map may be suitable
for this purpose[21;26]. These indices are based on the
simple \guilt by association" idea: two proteins shar-
ing a large number of common partners are more likely
to be co-located and to participate in the same cellular
processes; and thus they are more likely to interact[21].
The most direct formulation of this idea is the adjusted
CD-distance index[26],
AdjustCD(u;v) =
2jNu \ Nvj
jNuj + ¸u + jNvj + ¸v
where Nu and Nv are respectively the sets of neigh-
bours of proteins u and v, and ¸u and ¸v are used
to penalized proteins with very few neighbours. An
edge (u;v) is more likely to be a real interacting pair
if AdjustCD(u;v) is a high value. This idea can be
applied along with an expectation maximization pro-
cess to achieve even better cleansing performance[26].
Speci¯cally, de¯ne
wk+1(u;v) =
P
x2Nu\Nv(wk(x;u) + wk(x;v))
P
x2Nu wk(x;u) + ¸k
u +
P
x2Nv wk(x;v) + ¸k
v
where wk(x;u) is the score of (x;u) in the k-th iter-
ation; and w0(x;u) = 1 when there is an edge (x;u)
in the original (unclean) protein interaction network
and w0(x;u) = 0 otherwise. It is easy to see that
w1(u;v) = AdjustCD(u;v).
Fig.1. Edges in the DIP yeast interaction database are ranked
by AdjustCD and other reliability indices. The ¯gure shows the
correlation of these indices to functional homogeneity (a) and
localization coherence (b).
In spite of its simplicity, this idea works very well.
Fig.1 shows the correlation of AdjustCD and a few other
related indices to functional homogeneity and localiza-
tion coherence in the DIP yeast interaction database[20].Limsoon Wong et al.: Interactome Analysis for Drug Resistance 3
Note that DIP is quite noisy and the probability of two
proteins in an edge in DIP being in the same cellular
location is less than 55%. It can be seen from Fig.1 that
proteins in the 3000 top-ranked edges by these indices
have more than 70% probability of being in the same
cellular locations and thus are much more likely to be
capable of real interactions in vivo than other edges in
DIP.
Nonetheless, there is still much room to further im-
prove reliability assessment indices for cleaning protein
interactions. For example, AdjustCD has inherent limi-
tation when applied on a sparse partially protein inter-
actome map, as its formulation implicitly requires the
proteins being considered to have su±cient number of
partners.
3 Paucity of Bacterial Interactome Maps
We have earlier suggested M. tuberculosis as the tar-
get bacterial species because the emergence of drug-
resistant tuberculosis is posing a major threat to global
tuberculosis eradication programs[3]. However, very
few bacterial species have been analyzed at the pro-
teome level for protein interactions. In particular, only
a small partially inferred M. tuberculosis interactome
map is currently available[3]. To deal with this chal-
lenge, we need to develop techniques for (i) transferring
conserved interactions from other bacterial interactome
maps, (ii) predicting de novo protein interactions and
protein complexes, and (iii) mining protein interactions
from biological literature.
3.1 Transfer Conserved Interactions
It is necessary to integrate as many bacterial inter-
actome maps as possible to form a more comprehensive
interactome map for M. tuberculosis. Possible interac-
tome maps that can serve as starting points include C.
jejuni[15] and E. coli[16].
A major issue in inferring conserved protein interac-
tions is the determination of orthologs whose function
and interaction are highly likely to be conserved from
one bacterium to another. Candidate orthologs can be
obtained through a pre-computed data source such as
OMA[27]. However, the mapping is not guaranteed to
be unique as OMA is primarily based on evolutionary
distance derived from pairwise sequence comparison[28].
It is probably necessary to use conserved gene clus-
ters to disambiguate orthologs that are not uniquely
mapped[29]. The inference of conserved gene cluster is
non-trivial. Perhaps the recently developed approach
based on the idea of gene team tree[30] is helpful here.
The article by Tao Jiang[31] in this special issue pro-
vides further insights and discussions on this topic.
3.2 Infer Protein Interactions
It is important to infer some protein interactions
de novo to supplement the paucity of known protein
interactions information. There already exists a varie-
ty of protein-protein interaction prediction techniques,
including domain-domain interactions[32], interaction
motifs[33], paralogous interactions[34], protein function
similarity[35], protein coevolution information[36], as
well as data mining technique to identify domain or
functional combination pairs associated with interact-
ing proteins to derive complex interaction rules[25].
Interestingly, the AdjustCD index described in the
previous section can be made into a technique for
de novo protein interaction prediction based on topo-
logy of protein interactome maps! In particular, one
can predict proteins (u;v) to interact if the score
AdjustCD(u;v) is high. Fig.2 shows that the top 1000
new interactions in yeast (which are edges missing in
DIP) predicted by AdjustCD have more than 60% prob-
ability of being functionally homogeneous and more
Fig.2. New yeast protein interactions predicted using AdjustCD
and other reliability indices based on the DIP yeast protein in-
teraction database. The ¯gure shows these new edges have high
functional homogeneity (a) and localization coherence (b).4 J. Comput. Sci. & Technol., Jan. 2010, Vol.25, No.1
than 80% probability of being in the same cellular com-
partment, suggesting their strong likelihood to be real
interactions[37].
Nevertheless, there is considerable room for
improvement as current best-in-class approaches, which
already integrate many of the techniques mentioned,
are only achieving an ROC score of just above 63%[25].
3.3 Infer Protein Complexes
It is desirable to investigate techniques for predict-
ing protein complexes and functional modules from
an interactome map to derive higher-level information
for the interactome map. Several algorithms based
on graph clustering, dense region ¯nding, or clique
¯nding have been developed to discover protein com-
plexes from protein interaction networks, including
MCL[38], RNSC[39], DPClus[40], CFinder[41], PCP[42],
and CMC[26]. These algorithms are based on the as-
sumption that proteins in a complex have much denser
mutual interactions between themselves than with pro-
teins outside of the complex. However, these algorithms
have low sensitivity and low precision[42-43].
Fig.3. Precision and recall of CMC and MCL on Aloy (a) and
MIPS (b) datasets are improved signi¯cantly after the input pro-
tein interactome map is cleansed using AdjustCD.
One reason for this low sensitivity and precision
is the noise in protein interactome maps. This is
con¯rmed by an analysis[26], which shows that cleans-
ing the input interactome map has a large positive im-
pact on algorithms for inferring protein complexes from
the interactome map. For example, as shown in Fig.3,
the popular MCL algorithm[38] nearly doubles its pre-
cision and recall on the Aloy[44] and MIPS[45] datasets
of yeast protein complexes, after the input protein in-
teractome map is cleansed using AdjustCD. Thus the
earlier suggested challenge on increasing the reliability
of protein interactome should directly bene¯t protein
complex prediction.
Fig.4. Edge density of yeast protein complexes computed based
on protein interactomes from the popular BioGRID database.
Another cause for the low sensitivity and low pre-
cision of protein complex prediction algorithms is that
they cannot predict complexes that are small or have
low edge density, due to their assumption on high edge
density. However, complexes having low density of pro-
tein interactions are by far more common than high-
density ones! As evident in Fig.4, most yeast complexes
in MIPS[45] have edge density no more than 30% with
respect to protein-protein interactions in BioGRID[46].
So protein complex prediction needs new ideas that do
not rely on assuming dense interactions in the protein
interaction network.
3.4 Mine Biological Literature
There is a limit to the number of new protein in-
teractions and protein complexes that can be predicted
reliably. At the same time, new protein interactions and
complexes are also being reported in the scienti¯c litera-
ture. It is important that such new information be cap-
tured into an integrated database of bacterial interac-
tome maps as soon as possible. Such a database should
also be enhanced with information such as the known
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involved in drug resistance.
This calls for e®ective tools for mining literature
abstracts in Pubmed, reports in US FDA website, and
databases like PharmGKB[47]. Such tools should in-
clude ability for automated extraction of drug-enzyme
and protein-protein interactions from literature.
Recent progress on protein interaction extraction
from literature[48] is promising, achieving sensitivity
and precision above 80% on a small set of sentences.
However, the performance of these literature mining
tools on the whole-Pubmed scale has not been satis-
factorily evaluated to date. The extraction of drug-
enzyme interaction information from literature is even
less mature. The article by Hong-Jie Dai et al. in this
special issue[49] is a good resource for further insights
and discussions on this topic.
4 Identify Candidate Pathways to Drug
Resistance in Bacteria
Removal or suppression of critical proteins on an es-
sential pathway or complex is expected to disrupt the
pathway or complex and prohibit the pathogen from
performing a vital function[50]. Thus disconnecting
multiple pathways should e®ectively disrupt the sur-
vival of the bacteria. This brings us to the concept of
co-targets[3], whereby a combination of drugs is used to
simultaneously suppress several critical proteins, to re-
duce the emergence of drug resistance. This approach
to suppressing drug resistance in bacteria requires tech-
niques for (i) identifying essential pathways to drug re-
sistance in a bacterium, and (ii) ¯nding e®ective co-
targets on these pathways to disrupt.
4.1 Identify Pathways
The general known mechanisms for drug resistance
in bacteria include e²ux pumps to transport drugs out
of the cell, cytochromes-like enzymes that chemically
modify the drug, and horizontal gene transfer that im-
ports a detoxifying protein from the environment[4;51].
For each of these mechanisms, there are at least two
pathways to be identi¯ed. The ¯rst is the pathway by
which the speci¯c e²ux pump, drug-modifying enzyme,
or detoxifying protein is produced and activated. The
second is the pathway through which the drug or its
toxic downstream metabolites come into contact with
the speci¯c e²ux pump, drug modifying enzyme, or
detoxifying protein.
The identi¯cation of the ¯rst type of pathways is by
now an established problem in computational biology.
It involves classical topics such as discovering transcrip-
tion factors and their binding sites[52] on the genes for
the e²ux pump, drug-modifying enzyme, or detoxify-
ing protein.
The identi¯cation of the second type of pathways
is one of the interesting new challenges in countering
bacterial drug resistance. Although there is no clear
formulation yet, an extensive use of gene regula-
tory network and protein interaction network informa-
tion appears inevitable[18]. For example, Raman and
Chandra[3] formulated it as a search for shortest paths
of interacting proteins, in the relevant bacterial pro-
tein interactome map, that connect the direct targets
of a given drug to e²ux pumps, drug modifying en-
zymes, or detoxifying proteins. These paths are then
further culled by correlating with gene expression data
obtained from the bacteria after exposure to the drug.
However, this formulation has an obvious weakness.
It assumes that the shortest paths are the only routes
to escape or counter the e®ect of the drug. Nature is
known to be full of \back-up". If there are two dis-
joint paths between a drug target and (say) an e²ux
pump, disrupting the shorter path may simply channel
the °ux to the longer one and thus the drug may still
be pumped out of the bacterial cell.
Also, the genome of the drug-resistant strain and
non-drug-resistant strain of the pathogen should be
compared to identify extra genes in the former. The
protein products of these extra genes are worth consi-
dering as components of drug-resistance pathways.
4.2 Select Co-Targets
Proteins and interactions on such paths described
in the previous subsection are candidate co-targets. A
combination of complementary drugs that inhibit them
should disrupt pathways that confer resistance to the
main drug; thus allowing the main drug to kill the bac-
teria. For practical purposes, it is preferable to limit
the set of complementary drugs to be as small or as
cheap as possible.
If, for each path, there is at least one known drug
that inhibits a co-target on that path, choosing the
smallest or cheapest set of complementary drugs is
related to the vertex cover problem, which is NP-
complete[53]. If, for some path, there is no known drug
that inhibits any co-target on that path, the problem
becomes related to the multicut problem or minimum
bisection problem, which are NP-hard[54-55]. In either
case, the challenge promises to be interesting.
5 Closing Remarks
The emergence of drug resistance in bacteria is a
serious global threat. Even though the repertoire of
bacterial drug resistance mechanisms is still limited[4],
there has not been much success in countering these
drug resistance mechanisms. It is hoped that new in-
sights to bacterial drug resistance can be gained by a6 J. Comput. Sci. & Technol., Jan. 2010, Vol.25, No.1
systems-level analysis of bacterial gene regulation and
protein interaction networks[3;18].
The unreliability and paucity of bacterial
interactome maps are key obstacles to such a systems-
level analysis. In this paper, we have outlined some
current solutions and/or suggested possible approaches
to these issues from the computational perspective. In
particular, we have described the need to develop tech-
niques to assess reliability of protein interactions that
can work on a sparse input protein interactome map
without requiring much annotations on the proteins.
We have pointed out the need to develop techniques
to predict protein complexes from protein interactome
maps that can identify protein complexes that have
low edge density. We have also highlighted the need
to formulate new ways to identify pathways through
which a bacterium achieves resistance to a drug. Much
work remains to be done indeed!
References
[1] Antimicrobial Resistance Interagency Task Force 2007 Annual
Report. CDC USA. 2008.
[2] Johnson R et al. Drug resistance in mycobacterium tubercu-
losis. Curr. Issues Mol. Biol., 2006, 8(2): 97-111.
[3] Raman K, Chandra N. Mycobacterium tuberculosis interac-
tome analysis unravels potential pathways to drug resistance.
BMC Microbiol., 2008, 8: 234.
[4] Nguyen L, Thompson C J. Foundations of antibiotic resis-
tance in bacteria physiology: The mycobacterial paradigm.
Trends Microbiol., 2006, 14(7): 304-312.
[5] Uetz P, Giot L, Cagney G, Mans¯eld T A et al. A comprehen-
sive analysis of protein-protein interactions in Saccharomyces
cerevisiae. Nature, 2000, 403(6770): 623-627.
[6] Ito T, Chiba T, Ozawa R, Yoshida M et al. A comprehensive
two-hybrid analysis to explore the yeast protein interactome.
Proc. Natl. Acad. Sci. USA, 2001, 98(8): 4569-4574.
[7] Li S, Armstrong C M, Bertin N et al. A map of the inter-
actome network of the metazoan C. elegans. Science, 2004,
303(5657): 540-543.
[8] Giot L, Bader J S, Brouwer C, Chaudhuri A et al. A protein
interaction map of drosophila melanogaster. Science, 2003,
302(5651): 1727-1736.
[9] Rual J F, Venkatesan K, Hao T et al. Towards a proteome-
scale map of the human protein-protein interaction network.
Nature, 2005, 437(7062): 1173-1178.
[10] Stelzl U, Worm U, Lalowski M, Haenig C et al. A human
protein-protein interaction network: A resource for annotat-
ing the proteome. Cell, 2005, 122(6): 957-968.
[11] Gavin A C, Aloy P, Grandi P, Krause R et al. Proteome sur-
vey reveals modularity of the yeast cell machinery. Nature,
2006, 440(7084): 631-636.
[12] Krogan N J, Cagney G, Yu H et al. Global landscape of pro-
tein complexes in the yeast saccharomyces cerevisiae. Nature,
2006, 440(7084): 637-643.
[13] Collins S R, Kemmeren P, Zhao X C et al. Towards a com-
prehensive atlas of the physical interactome of saccharomyces
cerevisiae. Molecular & Cellular Proteomics, 2007, 6(3): 439-
450.
[14] Rain J C, Selig L, De Reuse H et al. The protein-protein inter-
action map of Helicobacter pylori. Nature, 2001, 409(6817):
211-215.
[15] Parrish J R, Yu J, Liu G, Hines J A et al. A proteome-wide
protein interaction map for campylobacter jejuni. Genome
Biology, 2007, 8(7): R130.
[16] Su C et al. Bacteriome.org|An integrated protein interaction
database for E. coli. Nucleic Acid Res., 2008, 36(Supplement
1): D632-D636.
[17] Hart G T, Ramani A K, Marcotte E M. How complete are cur-
rent yeast and human protein-interaction networks? Genome
Biology, 2006, 7(11): 120.
[18] Bailer S M, Haas J. Connecting viral with cellular interac-
tomes. Current Opinion in Microbiology, 2009, 12(4): 453-
459.
[19] Sprinzak E, Sattath S, Margalit H. How reliable are experi-
mental protein-protein interaction data? Journal of Molecu-
lar Biology, 2003, 327(5): 919-923.
[20] Xenarios I, Salwinski L, Duan X J, Higney P et al. DIP, the
database of interacting proteins: A research tool for study-
ing cellular networks of protein interactions. Nucleic Acids
Research, 2002, 30(1): 303-305.
[21] Chua H N, Wong L. Increasing the reliability of protein inter-
actomes. Drug Discovery Today, 2008, 13(15/16): 652-658.
[22] Nabieva E, Jim K, Agarwal A, Chazelle B, Singh M.
Whole-proteome prediction of protein function via graph-
theoretic analysis of interaction maps. Bioinformatics, 2005,
21(Suppl.1): i302-i310.
[23] Hart G T, Lee I, Marcotte E M. A high-accuracy consen-
sus map of yeast protein complexes reveals modular nature of
gene essentiality. BMC Bioinformatics, 2007, 8(1): 236.
[24] Ramani A K, Bunescu R C, Mooney R J, Marcotte E M.
Consolidating the set of known human protein-protein inter-
actions in preparation for large-scale mapping of the human
interactome. Genome Biology, 2005, 6(5): R40.
[25] Chua H N, Hugo Willy, Liu G, Li X L, Wong L, Ng S-K.
A probabilistic graph-theoretic approach to integrate multi-
ple predictions for the protein-protein subnetwork prediction
challenge. Annals of New York Academy of Sciences, 2009,
1158: 224-233.
[26] Liu G, Wong L, Chua H N. Complex discovery from weighted
PPI networks. Bioinformatics, 2009, 25(15): 1891-1897.
[27] Schneider A et al. OMA Browser|Exploring orthologous re-
lations across 352 complete genomes. Bioinformatics, 2007,
23(16): 2180-2182.
[28] Roth A et al. Algorithm of OMA for large-scale orthology
inference. BMC Bioinformatics, 2008, 9: 518.
[29] Pertea M et al. OperonDB: A comprehensive database of
predicted operons in microbial genomes. Nucleic Acid Res.,
2009, 37(Database Issue): D479-D482.
[30] Zhang M, Leong H W. Gene team tree: A compact tree repre-
sentation of all gene teams. In Proc. RECOMB Workshop on
Comparative Genomics (RCG), Paris, France, October 13-15,
2008, pp.100-112.
[31] Jiang T. Some algorithmic challenges in genome-wide orthol-
ogy assignment. Journal of Computer Science and Technol-
ogy, 2010, 25(1):
[32] Li X L et al. Improving domain-based protein interaction pre-
diction using biologically-signi¯cant negative dataset. Inter-
national Journal of Data Mining and Bioinformatics, 2006,
1(2): 138-149.
[33] Li H, Li J, Wong L. Discovering motif pairs at interaction
sites from sequences on a proteome-wide scale. Bioinformat-
ics, 2006, 22(8): 989-996.
[34] Mika S, Rost B. Protein-protein interactions more conserved
within species than across species. PLoS Comput Biology,
2006, 2(7): 379.
[35] Wu X et al. Prediction of yeast protein-protein interaction
network: Insights from the Gene Ontology and annotations.
Nucleic Acid Res., 2006, 34(7): 2137-2150.Limsoon Wong et al.: Interactome Analysis for Drug Resistance 7
[36] Juan D, Pazos F, Valencia A. High-con¯dence prediction
of global interactomes based on genome-wide coevolutionary
networks. Proc. Natl. Acad. Sci. USA, 2008, 105(3): 934-
939.
[37] Liu G, Li J, Wong L. Assessing and predicting protein interac-
tions using both local and global network topological metrics.
In Proc. the 19th Int. Conf. Genome Informatics (GIW),
Gold Coast, Australia, December 1-3, 2008, pp.138-149.
[38] Enright A J, Van Dongen S, Ouzounis C A. An e±cient al-
gorithm for large-scale detection of protein families. Nucleic
Acids Research, 2002, 30(7): 1575-1584.
[39] Przulj N, Wigle D. Functional topology in a network of pro-
tein interactions. Bioinformatics, 2003, 20(3): 340-348.
[40] Altaf-Ul-Amin M et al. Development and implementation of
an algorithm for detection of protein complexes in large in-
teraction networks. BMC Bioinformatics, 2006, 7: 207.
[41] Adamcsek B et al. CFinder: Locating cliques and overlapping
modules in biological networks. Bioinformatics, 2006, 22(8):
1021-1023.
[42] Chua H N, Ning K, Sung W-K, Leong H W, Wong L. Us-
ing indirect protein-protein interactions for protein complex
prediction. Journal of Bioinformatics and Computational Bi-
ology, 2008, 6(3): 435-466.
[43] Leung H C M et al. Predicting protein complexes from PPI
data: A core-attachment approach. J. Comput. Biol., 2009,
16(2): 133-164.
[44] Aloy P et al. Structure-based assembly of protein complexes
in yeast. Science, 2004, 303(5666): 2026-2029.
[45] Mewes H W et al. MIPS: Analysis and annotation of proteins
from whole genomes. Nucleic Acids Res., 2004, 32(Database
Issue): D41-D44.
[46] Stark C, Breitkreutz B J, Reguly T, Boucher L et al. Bio-
GRID: A general repository for interaction datasets. Nucleic
Acids Research, 2006, 34(Database Issue): D535-D539.
[47] Altman R B. PharmGKB: A logical home for knowledge re-
lating genotype to drug response phenotype. Nature Genet.,
2007, 39(4): 426.
[48] Chowdhary R, Zhang J, Liu J S. Bayesian inference of protein-
protein interactions from biological literature. Bioinformat-
ics, 2009, 25(12): 1536-1542.
[49] Dai H J, Chang Y C, Tsai R T H et al. New challenges for bi-
ological text mining in the next decade. Journal of Computer
Science and Technology, 2010, 25(1):
[50] Strong M, Eisenberg D. The protein network as a tool for
¯nding novel drug targets. Progress in Drug Research, 2007,
64: 191-215.
[51] Smith P A, Romesberg F E. Combating bacteria and drug
resistance by inhibiting mechanisms of persistence and adap-
tation. Nat. Chem. Biol., 2007, 3(9): 549-556.
[52] Valouev A, Johnson D S, Sundquist A, Medina C et al.
Genome-wide analysis of transcription factor binding sites
based on ChIP-Seq data. Nature Methods, 2008, 5(9): 829-
834.
[53] Karp R M. Reducibility among combinatorial problems. In
Proc. Symp. Complexity of Computer Computations, New
York, USA, March 20-22, 1972, pp.85-103.
[54] Leighton T, Rao S. Multicommodity max-°ow min-cut the-
orems and their use in designing approximation algorithms.
JACM, 1999, 46(6): 787-832.
[55] Powers D. Graph partitioning by eigenvectors. Lin. Alg.
Appl., 1988, 101: 121-133.
Limsoon Wong is concurrently
a professor of computer science and
a professor of pathology at the Na-
tional University of Singapore. He
works mostly on knowledge discovery
technologies and their application to
biomedicine. He serves on the edi-
torial boards of Information Systems
(Elsevier), Journal of Bioinformatics
and Computational Biology (ICP),
Bioinformatics (OUP), and Drug Discovery Today (Else-
vier). He is a scienti¯c advisor to Semantic Discovery Sys-
tems (UK), Molecular Connections (India), and CellSafe In-
ternational (Malaysia).
Guimei Liu is a senior research
fellow at National University of Sin-
gapore School of Computing. She
received her Ph.D. degree in com-
puter science from Hong Kong Uni-
versity of Science and Technology in
2005. Her current research interests
include frequent pattern mining and
its applications, and protein interac-
tion networks mining and analysis.